Effect of tauroursodeoxycholic acid on ALT, GGT and viral load in patients with hepatitis C virus-related chronic hepatitis with reference to the genotype.
Belloni
G
G
Ferrari
L
L
Balduzzi
C
C
Barbieri
F
F
Insolia
R
R
Klersy
C
C
D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000187:drug effects*; D000998:Antiviral Agents / Q000627:therapeutic use*; D002756:Cholagogues and Choleretics / Q000627:therapeutic use*; D005260:Female; D005838:Genotype; D016174:Hepacivirus / Q000187:drug effects*; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000201:enzymology / Q000235:genetics / Q000821:virology; D006801:Humans; D008297:Male; D008875:Middle Aged; D013655:Taurochenodeoxycholic Acid / Q000627:therapeutic use*; D019562:Viral Load; D005723:gamma-Glutamyltransferase / Q000187:drug effects*
D000998:Antiviral Agents; D002756:Cholagogues and Choleretics; D013655:Taurochenodeoxycholic Acid; C031655:ursodoxicoltaurine; D005723:gamma-Glutamyltransferase; D000410:Alanine Transaminase